Sun Pharmaceutical Industries Ltd announced today the successful completion of its acquisition of InSite Vision Incorporated.

Shares of Sun Pharma were lower by at company posted a net profit after taxes, Minority Interest and Share of Profit/(Loss) of Associates of Rs. mn for the quarter ended September 2015

Sun Pharmaceuticals Industries Limited has announced that Sun Pharmaceutical Industries Ltd, along with its subsidiary ( Sun Pharma) has entered into a settlement agreement with Acorda Therapeutics, Inc. - See more at: http://ways2capital-review.blogspot.in/2015/10/sun-pharma-enters-into-agreement-with.html#sthash.Bqbs2zdI.dpuf

Dollar Advisory & Financial Services: Nifty Struggles Below Sun Pharma Loses Adani Ports Up

Sun Pharmaceutical Industries Sink on US Warning Letter

Sun Pharma Shares Surge After US Regulator Accepts Drug Application

AstraZeneca Pharma India and Sun Pharmaceutical Industries today said they have entered into a distribution services agreement for AstraZeneca’s brand Axcer, a new brand of ticagrelor, in India. - See more at: http://ways2capital-equitytips.blogspot.in/2015/06/sun-pharma-astrazeneca-in-distribution.html#sthash.Wg2ewbNP.dpuf

AstraZeneca Pharma India and Sun Pharmaceutical Industries today said they have entered into a distribution services agreement for AstraZeneca’s brand Axcer, a new brand of ticagrelor, in India.

Shares of Sun Pharmaceutical Industries gained 2.8 percent intraday Tuesday. On an annualised basis, - See more at: http://ways2capital.blogspot.in/2015/06/sun-pharma-up-3-raises-ranbaxys.html#sthash.UYkRxhLn.dpuf

Sun Pharma Advanced Research Co. Ltd (SPARC) has filed draft papers with the Securities and Exchange Board of India (Sebi) to raise up to Rs.

Shares of Sun Pharmaceutical Industries gained more than 1 percent Tuesday on completion of acquisition of Opiates business in Australia. - See more at: http://ways2capital-equitytips.blogspot.in/2015/09/sun-pharma-up-1-completes-acquisition.html#sthash.ns0cKyxJ.dpuf

Drug major Sun Pharmaceutical Industries on Wednesday said it has received approval from the US health regulator for its new drug application for acne treatment medicine--XiminoTM extended-release capsules.

Shares of Sun Pharmaceutical Industries, India’s largest drug maker, are currently trading 0.49% lower at Rs. 794.40 on BSE. The company has singed a global deal with ICGEB for treatment of Dengue. - See more at: http://ways2capital-equitytips.blogspot.in/2016/05/sun-pharma-trades-in-red-despite-deal.html#sthash.DSIxwmGu.dpuf

Shares of Sun Pharmaceutical Industries, India’s largest drug maker, are currently trading lower at Rs. on BSE. The company has singed a global deal with ICGEB for treatment of Dengue.

Drug major Sun Pharmaceutical Industries on Wednesday said it has received approval from the US health regulator for its new drug application for acne treatment medicine--XiminoTM extended-release capsules. - See more at: http://ways2capital-review.blogspot.in/2015/08/sun-pharma-gets-usfda-approval-for-acne.html#sthash.OBisNDqH.dpuf

Drug major Sun Pharmaceutical Industries on Wednesday said it has received approval from the US health regulator for its new drug application for acne treatment medicine--XiminoTM extended-release capsules.

Sun Pharmaceutical Industries Inc. Issues Voluntary Nationwide Recall of Riomet® (Metformin Hydrochloride Oral Solution) Manufactured by a Contract Manufacturer due to Microbial Contamination

Sun Pharmaceutical Industries Inc. Issues Voluntary Nationwide Recall of Riomet® (Metformin Hydrochloride Oral Solution) Manufactured by a Contract Manufacturer due to Microbial Contamination

Sun Pharmaceuticals Industries Ltd on Tuesday declined around 8% in the morning session after its overseas arm Taro Pharmaceuticals Industries Ltd

Sun Pharmaceuticals Industries Ltd on Tuesday declined around in the morning session after its overseas arm Taro Pharmaceuticals Industries Ltd reported weak earnings in the March quarter, reported a national news portal.

Glaxo to sell Port Fairy plant to Indian buyers. GlaxoSmithKline (GSK) revealed its opiates businesses in Port Fairy and Tasmania's Latrobe would be taken over by Sun Pharmaceutical Industries.

Glaxo to sell Port Fairy plant to Indian buyers

Shares of Sun Pharmaceutical Industries slipped 1 percent intraday Tuesday after the company's active pharma - See more at: http://ways2capital-equitytips.blogspot.in/2015/07/sun-pharma-falls-1-post-usfda-audit-of.html#sthash.Z5oOcKLk.dpuf

Sun Pharmaceutical Industries Ltd announced that one of its subsidiaries has received final approval from US FDA for its Abbreviated New Drug Application (ANDA) for generic version of Gleevec , Imatinib Mesylate tablets and Imatinib Mesylate tablets,

Drug major Sun Pharmaceutical Industries has said it has raised Rs 1,000 crore through issuance of non-convertible debentures (NCDs) on private placement basis. "Sun Pharma Laboratories Ltd, a whol...

Sun Pharma raises Rs 1,000 cr via NCDs

Drug major Sun Pharmaceutical Industries has said it has raised Rs 1,000 crore through issuance of non-convertible debentures (NCDs) on private placement basis. "Sun Pharma Laboratories Ltd, a whol...

Shares of Sun Pharmaceutical Industries Ltd are currently trading 1.50% higher at Rs. 770.35 on BSE after it was reported by a financial daily that the company will raise Rs. 1,000 crore from the domestic bond market via its arm Sun Laboratories.

Shares of Sun Pharmaceutical Industries Ltd are currently trading higher at Rs. on BSE after it was reported by a financial daily that the company will raise Rs. crore from the domestic bond market via its arm Sun Laboratories.

Sun Pharmaceutical Industries Ltd has announced the following consolidated results for the quarter ended June 30, 2016:

Sun Pharma ended lower at on BSE. The pharma company received a Warning Letter from the US FDA as a result of the September 2014 inspection, for its facility located at Halol, Gujarat in India.

Pinterest
Search